Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection

[1]  Y. Nagai,et al.  Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface , 1996, Journal of virology.

[2]  C. Grose,et al.  Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. , 1995, Virology.

[3]  C. Grose,et al.  Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. , 1994, Virology.

[4]  H. Kamiya,et al.  Inhibition of varicella-zoster virus (VZV) glycoprotein expression by a human monoclonal antibody against VZV glycoprotein III. , 1993, The Journal of infectious diseases.

[5]  K. Yamanishi,et al.  Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus. , 1992, Antiviral research.

[6]  G. Wilkinson,et al.  Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted , 1992, Journal of virology.

[7]  Y. Masuho,et al.  A human monoclonal antibody against varicella-zoster virus glycoprotein III. , 1991, The Journal of general virology.

[8]  A. Fuller,et al.  Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration , 1989, Journal of virology.

[9]  D. Johnson,et al.  Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors , 1988, Journal of virology.

[10]  R. Hyman,et al.  The immediate early proteins of varicella-zoster virus. , 1987, Virology.

[11]  A J Davison,et al.  The complete DNA sequence of varicella-zoster virus. , 1986, The Journal of general virology.

[12]  C. Grose,et al.  Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). , 1986, Virology.

[13]  P. Keller,et al.  Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes , 1984, Journal of virology.

[14]  K. Yamanishi,et al.  Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. , 1983, Virology.

[15]  K. Yamanishi,et al.  Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). , 1982, The Journal of general virology.

[16]  K. Shiraki,et al.  Virus particles and glycoprotein excreted from cultured cells infected with varicella-zoster virus (VZV). , 1982, The Journal of general virology.

[17]  A. Neurath,et al.  Sialyl residues in hepatitis B antigen: their role in determining the life span of the antigen in serum and in eliciting an immunological response. , 1975, The Journal of general virology.

[18]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[19]  S. Matsui,et al.  Functional roles of terminal glycomoieties in varicella-zoster virus infection. , 1994, Virology.

[20]  C. Grose.  Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. , 1990, Annual review of microbiology.